Nguyen et al. 21 highlighted its role in bladder cancer staging and prognosis, emphasizing the need for further investigation into potential therapeutic interventions targeting aromatase in bladder cancer treatment. This evidence concerns the gene CYP19A1 and urinary bladder cancer.